Christoph Stephan | Infektiologie | Best Research Article Award

Published on by Cognitive Scientist Awards

Prof. Christoph Stephan | Infektiologie | Best Research Article Award

Universitätsklinik Frankfurt | Germany

Professor Christoph Stephan is a distinguished physician and academic leader in internal medicine and infectious diseases at University Hospital Frankfurt, Goethe University. He serves as the lead physician of the HIVCENTER, the largest university-based outpatient clinic for individuals living with HIV, and has coordinated numerous clinical trials as principal investigator. Renowned for his expertise in HIV pharmacotherapy, management of opportunistic infections, and antimicrobial stewardship, he combines clinical excellence with groundbreaking research. Stephan is an active member of national and international infectious disease societies and has contributed significantly to guideline development programs and educational initiatives. With extensive teaching, mentoring, and publication experience, he has shaped the careers of numerous healthcare professionals. His scholarly work demonstrates a commitment to advancing understanding of HIV and infectious diseases, optimizing patient care, and fostering collaboration between clinical practice and scientific research, establishing him as a global authority in his field.

Profile

ORCID

Education

Professor Stephan completed rigorous medical training and specialized education in internal medicine and infectious diseases, acquiring extensive knowledge of clinical care, pharmacotherapy, and diagnostic methods. His advanced studies included intensive coursework and practical rotations in infectious disease management, HIV care, and treatment of opportunistic infections. Through formal medical education, professional certification, and continuous clinical training, he developed expertise in patient-centered care, evidence-based practice, and research methodology. Stephan’s education also encompassed advanced learning in antimicrobial stewardship, clinical trials management, and guideline development. Complementing his medical degree, he participated in workshops, seminars, and professional development programs focused on HIV medicine, virology, immunology, and healthcare innovation. His education laid the foundation for academic and clinical excellence, enabling him to contribute to national and international scientific communities, mentor emerging professionals, and develop comprehensive care strategies for complex infectious diseases. His dedication to lifelong learning has strengthened his role as both a clinician and a researcher of global standing.

Experience

Professor Stephan has extensive experience as a senior physician and infectious disease specialist at University Hospital Frankfurt, Goethe University. He leads the HIVCENTER, providing comprehensive care to people living with HIV, and oversees numerous outpatient programs and clinical services. As a principal investigator in multiple clinical trials, he has coordinated interdisciplinary teams, managed research protocols, and contributed to scientific advancements in HIV pharmacotherapy and infectious disease treatment. Stephan has significant teaching and mentoring experience, guiding medical students, residents, and early-career researchers in clinical practice, research methodology, and patient care. He actively participates in the development of national and international guidelines, committees, and educational initiatives for infectious diseases. His experience spans clinical practice, research, publication, and policy development, demonstrating leadership, innovation, and commitment to healthcare excellence. Through his work, he has enhanced patient outcomes, advanced scientific knowledge, and strengthened the integration of research and practice in infectious disease management.

Awards and Honors

Professor Christoph Stephan has received recognition for his outstanding contributions to infectious disease research, HIV care, and medical education. He is widely respected for his leadership in clinical trials, scientific publications, and guideline development programs, earning acclaim from national and international professional societies. Stephan’s expertise in HIV medicine, antimicrobial stewardship, and treatment of opportunistic infections has been acknowledged through appointments to advisory boards, leadership roles in professional organizations, and invitations to speak at prestigious conferences. His scholarly achievements, including authorship of numerous textbook chapters and peer-reviewed publications, have further established him as a thought leader in the field. Awards and honors reflect his dedication to improving patient care, advancing medical science, and mentoring future generations of clinicians and researchers. Through recognition from professional associations, academic institutions, and research communities, Stephan’s contributions continue to inspire excellence in the practice and study of infectious diseases and HIV medicine worldwide.

Research Focus

Professor Stephan’s research centers on HIV pharmacotherapy, treatment of opportunistic infections, and antimicrobial stewardship. His work investigates the optimization of antiretroviral therapy, mechanisms of HIV resistance, and strategies to prevent and manage secondary infections in immunocompromised patients. Stephan also explores the clinical and virological outcomes of novel treatment regimens, contributing to evidence-based approaches that improve patient health and quality of life. He is deeply involved in clinical trials, evaluating the safety, efficacy, and long-term impacts of antiviral therapies. His research encompasses guideline development, translational studies, and the integration of clinical findings into routine patient care. By combining rigorous scientific inquiry with practical healthcare applications, Stephan advances understanding of HIV pathophysiology, treatment challenges, and therapeutic innovations. He collaborates with national and international research networks, contributing to multicenter studies, publications, and knowledge dissemination. His work aims to enhance treatment strategies, support personalized medicine, and improve global standards of care for people living with HIV.

 

Publications

 

Title: Clinical Epidemiology of Cancer in People Living with HIV in Germany: A Retrospective, Observational, Multicenter, Federated Claims Data Analysis
Year: 2025

Title: Effectiveness, safety, and patient‐reported outcomes of emtricitabine/tenofovir alafenamide‐based regimens for the treatment of HIV‐1 infection: Final 24‐month results from the prospective German TAFNES cohort study
Year: 2025

Title: Antiretroviral treatment in PLWH with late diagnosis initiating ART with DTG/3TC or BIC/TAF/FTC: a real-world cohort analysis
Year: 2024

Title: Care interruptions and mortality among adults in Europe and North America
Year: 2024

Title: Coinfections and antimicrobial treatment in a cohort of falciparum malaria in a non-endemic country: a 10-year experience
Year: 2024

Title: Differences in the Course of CD4 and CD8 Cells After Chemoradiotherapy in People Living with HIV with Anal Cancer
Year: 2024

Title: HIV treatment with maraviroc: forgotten, not needed or still useful? Results from the MIRROR study
Year: 2024

Conclusion

Professor Christoph Stephan exemplifies excellence in clinical practice, research, and education in infectious diseases and HIV medicine, combining innovative research with compassionate patient care, impactful teaching, and leadership in guideline development, advancing global healthcare standards, improving patient outcomes, and inspiring the next generation of clinicians and researchers.

Tianle Gao | Antifungal Medicine | Best Researcher Award

Published on by Cognitive Scientist Awards

Prof. Tianle Gao | Antifungal Medicine | Best Researcher Award

Chinese Academy of Medical Sciences and Peking Union Medical College | China

Tianle Gao is a distinguished pharmacology researcher from the People’s Republic of China, serving as an Associate Researcher at the Institute of Materia Medica, Chinese Academy of Medical Sciences. With advanced training in pharmacology and neuropharmacology at globally renowned institutions in Sweden, Dr. Gao has established a strong research profile in the fields of drug discovery and medicinal sciences. He actively contributes to scientific development through his editorial roles in leading pharmaceutical journals and his service as a youth member of the Pharmaceutical Affairs Management Committee of the Chinese Pharmaceutical Association. His research integrates pharmacological principles with translational approaches to address unmet medical needs. Dedicated to advancing medicinal biotechnology and pharmacological innovation, Dr. Gao is recognized for his scholarly contributions, leadership in scientific communities, and commitment to fostering the next generation of researchers. His multidisciplinary expertise reflects a global vision combined with national dedication to healthcare advancement.

Profile

Scopus

Education

Tianle Gao pursued his doctoral studies in pharmacology at the prestigious Karolinska Institute in Sweden, where he developed a deep foundation in pharmacological mechanisms and therapeutic development. His academic journey emphasized experimental pharmacology, molecular biology, and the study of drug action in complex biological systems. Following this, he expanded his academic experience through postdoctoral training at Uppsala University BMC in Sweden, where he specialized in neuropharmacology research. This stage of his education provided him with expertise in neurochemical processes, signaling pathways, and the pharmacological basis of neurological disorders. His academic training combines international exposure with rigorous scientific inquiry, enabling him to bridge fundamental pharmacology with applied medicinal sciences. By engaging with multidisciplinary perspectives and collaborating across borders, Dr. Gao has cultivated a comprehensive understanding of drug development, neuropharmacology, and translational medicine. His educational background continues to inform his research, shaping his innovative approach to advancing pharmacological and therapeutic sciences.

Experience

With a career shaped by global academic training and national scientific service, Tianle Gao currently holds the position of Associate Researcher at the Institute of Materia Medica, Chinese Academy of Medical Sciences. His role emphasizes pharmacological research and development, particularly in advancing medicinal biotechnology and therapeutic solutions. Beyond his institutional appointment, he contributes significantly to the broader pharmaceutical community through active service in professional organizations. As a youth member of the Pharmaceutical Affairs Management Committee of the Chinese Pharmaceutical Association, he participates in shaping research agendas and pharmaceutical policies. His editorial responsibilities with leading journals such as China Medicinal Biotechnology, Acta Pharmaceutica Sinica, and Acta Pharmaceutica Sinica B highlight his dedication to scholarly dissemination and peer mentorship. His professional journey reflects a balance of laboratory research, academic publishing, and scientific leadership. Through these combined experiences, he plays a critical role in strengthening pharmacological sciences both nationally and internationally.

Awards and Honors

Tianle Gao has received recognition for his excellence in research, leadership, and contributions to pharmacology and medicinal sciences. His academic achievements and service in professional organizations have earned him respect as a promising scholar and emerging leader. He has been honored with distinctions such as the Distinguished Scientist Award, Young Scientist Award, and Best Researcher Award, reflecting his commitment to advancing pharmacological knowledge. In recognition of his innovative research, he has also been awarded the Best Innovation Award and Excellence in Research honors. His involvement as a youth editorial board member of highly respected journals further underscores his scholarly reputation. These recognitions serve as a testament to his sustained contributions to pharmacological science and his efforts to mentor young researchers. Through these honors, Dr. Gao continues to be acknowledged as a researcher who bridges global academic training with national scientific advancement.

Research Focus

Tianle Gao’s research is centered on pharmacology, neuropharmacology, and medicinal biotechnology, with a strong emphasis on translating scientific discoveries into therapeutic solutions. His work explores the molecular mechanisms of drug action, the pharmacological pathways underlying neurological disorders, and innovative strategies for drug discovery and development. By integrating basic pharmacological research with applied medicinal studies, he contributes to the advancement of treatments for complex diseases. His focus also includes the exploration of bioactive compounds, pharmacokinetics, and safety evaluations, ensuring that research outcomes can progress toward clinical application. His participation in major research projects, publication of scholarly articles, and contributions to scientific committees reflect his dedication to advancing global knowledge in pharmacology. Through international collaborations and editorial leadership, he promotes the dissemination of high-quality research. His research philosophy combines innovation with translational impact, aiming to address healthcare challenges and improve therapeutic strategies for human well-being.

 

Publications

 

Title: Isochlorogenic Acid C Alleviates Allergic Asthma via Interactions Between Its Bioactive Form and the Gut Microbiome
Year: 2025

Title: Exploring the transcriptome of resident spinal microglia after collagen antibody-induced arthritis
Year: 2019

Title: Sinomenine facilitates the efficacy of gabapentin or ligustrazine hydrochloride in animal models of neuropathic pain
Year: 2019

Title: The Neuropeptide Y System Regulates Both Mechanical and Histaminergic Itch
Year: 2018

Conclusion

Tianle Gao is a globally trained pharmacology researcher whose expertise, experience, and recognized contributions in drug discovery, neuropharmacology, and medicinal biotechnology continue to strengthen pharmaceutical sciences and inspire innovation in healthcare advancement.

Mohammad Ebrahimipour | Microbiology | Best Researcher Award

Published on by Cognitive Scientist Awards

Prof Dr. Mohammad Ebrahimipour | Microbiology | Best Researcher Award

 

 

Profile

Education

He holds a PhD in Medical Parasitology from the Department of Parasitology & Mycology at Shiraz University of Medical Sciences, Shiraz, Iran (2017). He earned his MSPH in Medical Parasitology from the School of Public Health & Institute of Public Health Research at Tehran University of Medical Sciences, Tehran, Iran (2012). Additionally, he completed his B.Sc. in Medical Entomology from the School of Public Health at Bandar Abbas University of Medical Sciences, Bandar Abbas, Iran (2008).

 

Work experience

He has presented several research abstracts at prestigious scientific meetings. His work includes a meta-analysis on the prevalence of intestinal parasites among food handlers in Asian and African countries, presented at the 2nd International and 9th National Congress of Parasitology and Parasitic Diseases of Iran (NICOPA9) in Guilan, Iran (May 20–22, 2015). Additionally, he conducted a retrospective analysis of human hydatidosis in Khorasan Province, a hyperendemic area in Iran, which was also presented at NICOPA9.

Further, Dr. [Name] contributed to a study on the rate of Plasmodium vivax infectivity in individuals with glucose-6-phosphate dehydrogenase (G6PD) deficiency in Hormozgan Province, Iran, showcased at the same congress. Another significant presentation includes research on the prevalence and time-trend analysis of intestinal parasitic infections in Nazarabad, Alborz Province, Iran, based on data from 2012 to 2016, which was presented at the 3rd International and 10th National Congress of Parasitology and Parasitic Diseases of Iran (NICOPA10).

Research interest

He is a member of the Iranian Society of Parasitology since 2017. His research interests focus on the epidemiology of parasitic diseases, particularly vector-borne infections, as well as the clinical aspects and control strategies for parasitic diseases. His work aims to enhance understanding and develop effective interventions for managing parasitic infections in endemic regions.

 

Publication
  • Azizian, M., Oliaee, R.T., Karimazar, M.R., Ebrahimipour, M. and Afgar, A.,
    2023. Time Series Model for Forecasting the Prevalence of Some Important Parasitic
    Infections in Slaughtered Sheep in North-Central Iran. Arch Vet Sci, 27(4)
  • Najjari, M., Rezaeian, S., Sheikhbardsiri, H., Afgar, A. and Ebrahimipour, M.,
    2022. Evaluation of the Prevalence of Malaria and Cutaneous Leishmaniasis in the
    Pre-and Post-Disaster Years in Iran. Prehospital and disaster medicine, 37(4),
    pp.444-450.
  • Najjari, M., Karimazar, M., Ebrahimipour, M. and M Budke, C., 2022. A Review
    of Ethical Issues Related to Laboratory-Based Diagnostics. Medical Laboratory
    Journal, 16(2), pp.1-6.
  • Afgar, A., Vahidi, R., Ebrahimipour, M., Babaei, Z., Mirzaei-Parsa, M.J. and
    Ravari, M.S., 2021. The prediction and expression of miR-203a-p and miR-29b*
    against DNMT3B as well as TNFAIP3 in melanoma. Gene Reports, 25, p.101374.
  • Goudarzi, R., Fasihi Harandi, M., Tasavon Gholamhoseini, M. and Ebrahimipour,
    M., 2021. The Costs of Training Medical Parasitology and Mycology Students at
    Kerman University of Medical Sciences. Strides in Development of Medical
    Education, 18(1), pp.1-6.
  • Ebrahimipour, M., Budke, C.M. and Harandi, M.F., 2020. Control of cystic
    echinococcosis in Iran: where do we stand?. Trends in parasitology, 36(7), pp.578-
    581.